• 2013

Company Description

eTheRNA develops immunotherapies that target the fundamental role of dendritic cells in the human immune system.

eTheRNA immunotherapies' mission is to help patients to overcome certain cancers and infectious diseases by developing novel immunotherapies that target the fundamental role of dendritic cells in the human immune system. eTheRNA’s proprietary mRNA-based TriMix technology boosts dendritic cells leading to a more comprehensive, sustainable and safer enhancement of the patient’s immune system than any other similar approach investigated until now.

  • Manufacturer:

    Science and Engineering
  • Formed:

    2013
  • Company Website:

  • Company E-mail:

  • Company Address:

    VUB Campus Jette, Laarbeeklaan 103 – Building E
    Jette
    Belgium
  • We recognize our sponsors starting at $1 per entry.
    Learn more at https://www.ithistory.org/benefits